PRKR · Parkervision Inc

Option is awarded as compensation for 2026 Board service. Option vests in two, equal bi-annual increments on July 22, 2026 and January 22, 2027.

Option is exercisable in four, equal, bi-annual increments beginning July 22, 2026.

Option is awarded as compensation for 2026 Board service. Option vests in two, equal bi-annual increments on July 22, 2026 and January 22, 2027.

Option is awarded as compensation for 2026 Board service. Option vests in two, equal bi-annual increments on July 22, 2026 and January 22, 2027.

The option vests based ont he achievement of specified performance conditions measured quarterly during a five-year performance period. Any portion of the option that does not vest by January 22, 2031 will be cancelled.

The option vests based ont he achievement of specified performance conditions measured quarterly during a five-year performance period. Any portion of the option that does not vest by January 22, 2031 will be cancelled.

Reporting Person purchased 4,761,905 shares of ParkerVision common stock, $0.01 par value, for an aggregate purchase price of $1,000,000 or $0.21 per share, representing the last sale price of ParkerVision's common stock on November 14, 2025. The transaction closed on November 17, 2025. The offering was made pursuant to an existing shelf registration statement on Form S-3 that was declared effective by the SEC on May 28, 2025 (Registration No. 333-287427). The transaction was reviewed and approved by the disinterested directors of ParkerVision's board of directors in accordance with Section 607.0832 of the Florida Business Corporation Act.

Option vested in equal quarterly installments commencing January 27, 2024.

Optoin vested in four equal quarterly increments commencing May 1, 2024 and became fully exercisable February 1, 2025.

Restricted Stock Units ("RSU") awarded as 2025 director compensation. Each RSU entitles holder to one share of the Company's common stock, $0.01 par value, upon vesting. RSU vests 50% upon grant and 50% on December 31, 2025.

Beneficial ownership, for purposes of this filing, includes 137,500 shares issuable upon vesting of the RSU on December 31, 2025.

Restricted Stock Units ("RSU") awarded as 2025 director compensation. Each RSU entitles holder to one share of the Company's common stock, $0.01 par value, upon vesting. RSU vests 50% upon grant and 50% on December 31, 2025.

Beneficial ownership, for purposes of this filing, includes 137,500 shares that will be issued upon vesting of the RSU on December 31, 2025.

Option is awarded as compensation for 2025 Board service. Option vests 50% upon grant and 50% on December 31, 2025.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated May 10, 2022, as amended, with a face value of $200,000 and a fixed conversion price of $0.13.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated May 10, 2022, as amended, with a face value of $200,000 and a fixed conversion price of $0.13.

Transaction represents the modification of a fully vested option award granted on January 11, 2021 to extend the expiration date from January 11, 2026 to January 11, 2031. No other terms of the award were modified and no additional securities were issued.

Transaction represents the modification of a fully vested option award granted on January 11, 2021 to extend the expiration date from January 11, 2026 to January 11, 2031. No other terms of the award were modified and no additional securities were issued.

Interest in kind paid on Convertible Note dated May 10, 2022.

Interest in kind paid on Convertible Notes dated January 8, 2020 and May 10, 2022.

Interest in kind paid on Convertible Notes dated June 19, 2019 and September 13, 2019.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated September 15, 2023, as amended, with a face value of $100,000 and a fixed conversion price of $0.25.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated May 10, 2022, as amended, with a face value of $100,000 and a fixed conversion price of $0.13.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated May 10, 2022, as amended, with a face value of $100,000 and a fixed conversion price of $0.13.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated September 15, 2023, as amended, with a face value of $100,000 and a fixed conversion price of $0.25.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated June 19, 2019, as amended, with a face value of $25,000 and a fixed conversion price of $0.10.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated September 13, 2019, as amended, with a face value of $50,000 and a fixed conversion price of $0.10.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated January 8, 2020, as amended, with a face value of $50,000 and a fixed conversion price of $0.13.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated June 19, 2019, as amended, with a face value of $25,000 and a fixed conversion price of $0.10.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated January 8, 2020, as amended, with a face value of $50,000 and a fixed conversion price of $0.13.

Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated September 13, 2019, as amended, with a face value of $50,000 and a fixed conversion price of $0.10.

Option was awarded as 2024 compensation for board and committee service and is exercisable in four equal quarterly increments beginning 5/1/2024.

Option was awarded as 2024 compensation for board and committee service and is exercisable in four equal quarterly increments beginning 5/1/2024.

Option was awarded as 2024 compensation for board service and is exercisable in four equal quarterly increments beginning 5/1/2024.

Option was awarded as 2024 compensation for board and committee service and is exercisable in four equal quarterly increments beginning 5/1/2024.

Option vests in eight equal quarterly increments beginning February 18, 2024.

30-month convertible note at the Reporting Person's option to convert into shares of the Issuer's Common Stock at a fixed conversion price of $0.25 per share.

Form 4 is being amended to correct the transaction code.

Form 4 is being amended to correct the transaction code.

Reporting Person acquired shares of common stock as payment of interest-in-kind on a convertible note dated August 2022 with a principal balance of $25,000.

Restricted stock award represents share-based compensation awarded under the Company's 2019 Incentive Plan. Award has a fair value of $0.30 per share, or $60,000, in the aggregate.

Option was awarded as 2023 compensation for board service and is exercisable in four equal quarterly increments beginning 4/16/2023.

Option was awarded as 2023 compensation for board and audit committee service and is exercisable in four equal quarterly increments beginning 4/16/2023.

Restricted stock award represents share-based compensation awarded under the Company's 2019 Incentive Plan. Award has a fair value of $0.30 per share, or $60,000, in the aggregate.

Option was awarded as 2023 compensation for board and audit committee service and is exercisable in four equal quarterly increments beginning 4/16/2023.

Restricted stock award represents share-based compensation awarded under the Company's 2019 Incentive Plan. Award has a fair value of $0.30 per share, or $60,000, in the aggregate.

Option was awarded as 2023 compensation for board and audit committee service and is exercisable in four equal quarterly increments beginning 4/16/2023.

Board approved purchase in private placement transaction.